NVOS Stock Overview
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services.
Novo Integrated Sciences, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.24|
|52 Week High||US$3.32|
|52 Week Low||US$0.21|
|1 Month Change||-13.30%|
|3 Month Change||-85.36%|
|1 Year Change||-81.65%|
|3 Year Change||-96.69%|
|5 Year Change||-96.26%|
|Change since IPO||-97.16%|
Recent News & Updates
|NVOS||US Healthcare||US Market|
Return vs Industry: NVOS underperformed the US Healthcare industry which returned 9.3% over the past year.
Return vs Market: NVOS underperformed the US Market which returned -18.5% over the past year.
|NVOS Average Weekly Movement||22.9%|
|Healthcare Industry Average Movement||8.1%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: NVOS is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 23% a week.
Volatility Over Time: NVOS's weekly volatility has increased from 15% to 23% over the past year.
About the Company
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women’s pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services.
Novo Integrated Sciences, Inc. Fundamentals Summary
|NVOS fundamental statistics|
Is NVOS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NVOS income statement (TTM)|
|Cost of Revenue||US$16.70m|
Last Reported Earnings
May 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.35|
|Net Profit Margin||-54.75%|
How did NVOS perform over the long term?See historical performance and comparison